                         SEQUENCE LISTING

<110>  Ironwood Pharmaceuticals, Inc.
       Currie, Mark G.
       Zimmer, Daniel P.
       Fretzen, Angelika
       Kessler, Marco
       Cali, Brian
 
<120>  Treatments for Gastrointestinal Disorders

<130>  223355/106PCT1/328145

<140>  PCT/US12/XXXXXX
<141>  2012-06-08

<150>  61/494,685
<151>  2011-06-08

<160>  71    

<170>  PatentIn version 3.5

<210>  1
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is Asn, D-Asn, Gln, D-Gln, Pro, D-Pro, Ala, beta-Ala, D-Ala,
       Val, D-Val, Gly, Thr, D-Thr, Asp, D-Asp, beta-carboxylated Asp, 
       Gly, D-Glu, gamma-carboxylated Glu, alpha-aminosuberic acid 
       (Asu), alpha-aminoadipic acid (Aad), or alpha-aminopimelic acid (Apm) 
       

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is Asn, D-Asn, Gln, D-Gln, Pro, D-Pro, Ala, beta-Ala, D-Ala,
       Val, D-Val, Gly, Thr, D-Thr, Asp, D-Asp, beta-carboxylated Asp, 
       Glu, D-Glu, gamma-carboxylated Glu, alpha-aminosuberic acid 
       (Asu), alpha-aminoadipic acid (Aad), or alpha-aminopimelic acid 
       

<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  if Xaa1 is present, Xaa1 may be modified on its amino group by 
       methyl, ethanedioic acid, propanedioic acid, butanedioic acid, 
       pentanedioic acid, hexanedioic acid, heptanedioic acid or 
       octanedioic acid

<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  if both Xaa2 and Xaa3 are absent, then Xaa1 must be 
       beta-carboxylated Asp or gamma-carboxylated Glu

<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  or if both Xaa2 and Xaa3 are absent, then Xaa1 must be Asp, 
       D-Asp, Glu, D-Glu, Asu, Aad, or Apm and must be modified on its 
       amino group by ethanedioic, propanedioic, butanedioic, 
       pentanedioic, hexanedioic, heptanedioic or octanedioic acid

<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa1 is modified on its amino group at either or both hydrogen 
       atoms by methyl, ethanedioic acid, propanedioic acid, butanedioic
       acid, pentadioic acid, hexanedioic acid, heptanedioic acid or 
       octanedioic acid

<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa1 is not modified on its amino group when either or both of 
       Xaa2 and Xaa3 are present

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa2 is Asp, beta-carboxylated Asp, Glu, gamma-carboxylated Glu, 
       Asu, Aad, Apm, or is absent

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa2 is Asp, beta-carboxylated Asp, Glu, gamma-carboxylated Glu, 
       Asu, Aad, Apm, or is absent

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa3 is Asp, beta-carboxylated Asp, Glu, gamma-carboxylated Glu, 
       Asu, Aad, Apm, or is absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa4 is Cys or D-Cys

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa6 is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa7 is Tyr, Leu, Phe or Ile

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa8 is Cys or D-Cys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa14 is Thr, Ala or Phe

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa16 is Cys or D-Cys

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa17 is Tyr, D-Tyr, or is absent

<400>  1

Xaa Xaa Xaa Xaa Cys Xaa Xaa Xaa Cys Asn Pro Ala Cys Xaa Gly Xaa 
1               5                   10                  15      


Xaa 
    


<210>  2
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is Asn, D-Asn, Gln, D-Gln, Pro, D-Pro, Ala, B-Ala, D-Ala, 
       Val, D-Val, Gly, Thr, D-Thr, Asp, D-Asp, Glu or D-Glu

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa2 is Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa3 is Asp, Glu or is absent

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa7 is Tyr or Leu

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa17 is Tyr or is absent

<400>  2

Xaa Xaa Xaa Cys Cys Glu Xaa Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Xaa 
    


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  3

Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15  


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  4

Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15  


<210>  5
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  5

Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr 
1               5                   10                  15      


<210>  6
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  6

Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr 
1               5                   10                  15      


<210>  7
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  7

Asn Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  8
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  8

Asn Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  9
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  9

Asn Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  10
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  10

Asn Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  11
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sythetically generated peptide

<400>  11

Ala Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  12
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  12

Ala Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  13
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is beta-Ala

<400>  13

Xaa Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  14
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is beta-Ala

<400>  14

Xaa Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  15
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  15

Ala Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  16
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  16

Ala Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  17
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is beta-Ala

<400>  17

Xaa Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  18
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is beta-Ala

<400>  18

Xaa Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  19
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  19

Pro Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  20
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  20

Pro Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  21
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  21

Pro Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  22
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  22

Pro Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  23
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  23

Thr Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  24
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  24

Thr Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  25
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  25

Thr Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  26
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  26

Thr Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  27
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  27

Gly Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  28
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  28

Gly Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  29
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  29

Gly Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  30
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  30

Gly Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  31
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  31

Asp Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  32
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  32

Asp Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  33
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  33

Asp Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  34
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  34

Asp Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  35
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  35

Glu Glu Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15  


<210>  36
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  36

Glu Glu Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15  


<210>  37
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  37

Glu Glu Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr 
1               5                   10                  15      


<210>  38
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  38

Glu Glu Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr 
1               5                   10                  15      


<210>  39
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  39

Glu Glu Glu Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  40
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  40

Glu Glu Glu Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  41
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  41

Glu Glu Glu Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  42
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  42

Glu Glu Glu Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  43
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  43

Glu Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15  


<210>  44
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  44

Glu Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15  


<210>  45
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  45

Glu Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr 
1               5                   10                  15      


<210>  46
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  46

Glu Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr 
1               5                   10                  15      


<210>  47
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is D-Asp

<400>  47

Xaa Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  48
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is D-Ala

<400>  48

Xaa Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  49
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is D-Asn

<400>  49

Xaa Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  50
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is D-Ala

<400>  50

Xaa Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  51
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa17 is D-Tyr

<400>  51

Asp Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Xaa 
    


<210>  52
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is D-Asp

<400>  52

Xaa Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  53
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  53

Asn Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  54
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  54

Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr 
1               5                   10                  15      


<210>  55
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  55

Asp Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  56
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  56

Gly Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  57
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  57

Pro Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  58
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  58

Ala Asp Asp Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  59
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  59

Asn Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  60
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  60

Ala Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  61
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is beta-Ala

<400>  61

Xaa Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  62
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  62

Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr 
1               5                   10                  15      


<210>  63
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  63

Asp Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  64
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  64

Pro Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  65
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  65

Gly Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  66
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  66

Asp Asp Asp Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


<210>  67
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  67

Glu Glu Glu Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Tyr 
    


<210>  68
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa1 is Asn, D-Asn, Gln, D-Gln, Pro, D-Pro, Ala, beta-Ala, D-Ala,
       Val, D-Val, Gly, Thr, D-Thr, Asp, D-Asp, Glu or D-Glu

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa3 is Asp or is absent

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa7 is Tyr or Leu

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa17 is Tyr or is absent

<400>  68

Xaa Asp Xaa Cys Cys Glu Xaa Cys Cys Asn Pro Ala Cys Thr Gly Cys 
1               5                   10                  15      


Xaa 
    


<210>  69
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  69

Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr 
1               5                   10                  


<210>  70
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  70

Cys Cys Glu Phe Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr 
1               5                   10                  


<210>  71
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetically generated peptide

<400>  71

Asn Thr Phe Tyr Cys Cys Glu Leu Cys Cys Asn Pro Ala Cys Ala Gly 
1               5                   10                  15      


Cys Tyr 
        


